Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Taniguchi

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|July 28, 2016
The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?Mariko Morishita-Katsu, Koichi Nishimura, Hiroyuki Taniguchi, et al.
European Journal of Radiology|February 5, 2008
Nonspecific interstitial pneumonia: histologic correlation with high-resolution CT in 29 patientsHiromitsu Sumikawa, Takeshi Johkoh, Kazuya Ichikado, et al.
European Journal of Radiology|September 23, 2015
Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: The effect of the integrated clinico-radiological assessmentJunya Tominaga, Fumikazu Sakai, Takeshi Johkoh, et al.
The European Respiratory Journal|May 21, 2017
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosisHarold R Collard, Luca Richeldi, Dong Soon Kim, et al.
European Journal of Radiology|December 16, 2011
Usual interstitial pneumonia and nonspecific interstitial pneumonia: correlation between CT findings at the site of biopsy with pathological diagnosesHiromitsu Sumikawa, Takeshi Johkoh, Kiminori Fujimoto, et al.
Anti-Cancer Drugs|February 15, 2011
Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.
Anticancer Research|April 13, 2016
Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906Tomoki Kimura, Hiroyuki Taniguchi, Naohiro Watanabe, et al.
Lung|August 12, 2006
Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancerKensuke Kataoka, Ryujiro Suzuki, Hiroyuki Taniguchi, et al.
Respiratory Medicine|May 20, 2014
Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosisLuca Richeldi, Vincent Cottin, Kevin R Flaherty, et al.
Radiology|October 2, 2002
Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patientsTakeshi Johkoh, Nestor L Müller, Thomas V Colby, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Chronic Obstructive Pulmonary Disease|July 28, 2016
The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?Mariko Morishita-Katsu, Koichi Nishimura, Hiroyuki Taniguchi, et al.
European Journal of Radiology|February 5, 2008
Nonspecific interstitial pneumonia: histologic correlation with high-resolution CT in 29 patientsHiromitsu Sumikawa, Takeshi Johkoh, Kazuya Ichikado, et al.
European Journal of Radiology|September 23, 2015
Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: The effect of the integrated clinico-radiological assessmentJunya Tominaga, Fumikazu Sakai, Takeshi Johkoh, et al.
The European Respiratory Journal|May 21, 2017
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosisHarold R Collard, Luca Richeldi, Dong Soon Kim, et al.
European Journal of Radiology|December 16, 2011
Usual interstitial pneumonia and nonspecific interstitial pneumonia: correlation between CT findings at the site of biopsy with pathological diagnosesHiromitsu Sumikawa, Takeshi Johkoh, Kiminori Fujimoto, et al.
Anti-Cancer Drugs|February 15, 2011
Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404Osamu Nishiyama, Hiroyuki Taniguchi, Yasuhiro Kondoh, et al.
Anticancer Research|April 13, 2016
Phase II Study of Carboplatin and Pemetrexed in Advanced EGFR-wild-type Non-squamous Non-small Cell Lung Cancer: The Central Japan Lung Study Group Trial 0906Tomoki Kimura, Hiroyuki Taniguchi, Naohiro Watanabe, et al.
Lung|August 12, 2006
Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancerKensuke Kataoka, Ryujiro Suzuki, Hiroyuki Taniguchi, et al.
Respiratory Medicine|May 20, 2014
Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosisLuca Richeldi, Vincent Cottin, Kevin R Flaherty, et al.
Radiology|October 2, 2002
Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patientsTakeshi Johkoh, Nestor L Müller, Thomas V Colby, et al.
Pageof 18